Name: Latest research reports of Dr. Agarwals Health Care Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Dr. Agarwals Health Care Ltd.
Rating: 5
Author: Motilal Oswal

Dr. Agarwals Health Care Ltd.

NSE: AGARWALEYE | BSE: 544350 | ISIN: INE943P01029 | Industry: Healthcare Facilities
| Expensive Underperformer

425.5000 10.10 (2.43%)

NSE Sep 05, 2025 15:31 PM

30.12% Gain from 52W Low

Volume: 137.7K

Dr. Agarwals Health Care Ltd.

29 May 2025

425.50

2.43%

Ends FY25 on strong operational performance

Buy: Dr. Agarwals Health Care Ltd.

Target

Motilal Oswal

Dr. Agarwal’s Health Care (DAHL) delivered in-line Revenue/EBITDA for the quarter. However, there was a miss on earnings due to higher-thanexpected interest outgo for the quarter.

Dr. Agarwals Health Care Ltd. is trading below its 30 day SMA of 446.5